Showing results (1-10 of 105) with videos related to
Sort By:
Pageof 11
Clinical Pharmacology and Therapeutics|November 7, 2017
Buprenorphine in Neonatal Abstinence SyndromeWalter K KraftCurrent Therapeutic Research, Clinical and Experimental|November 8, 2014
Ethanol pharmacokinetics in neonates and infantsElizabeth Marek, Walter K KraftExpert Review of Clinical Pharmacology|August 9, 2011
Acid peptic diseases: pharmacological approach to treatmentAlex Mejia, Walter K KraftClinics in Perinatology|April 24, 2019
Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence SyndromeHendrée E Jones, Walter K KraftExpert Opinion on Drug Metabolism & Toxicology|August 28, 2010
Pharmacokinetic evaluation of fosaprepitant dimeglumineFrancheska Colon-Gonzalez, Walter K KraftExpert Opinion on Investigational Drugs|February 3, 2025
The role of 5-HT modulation in opioid withdrawal and neonatal opioid withdrawal syndrome: mechanisms and potential serotonergic targetsKevin Lam, Gary Peltz, Walter K KraftExpert Review of Clinical Pharmacology|May 12, 2017
Tumor necrosis factor inhibitors in psoriatic arthritisSanthi Mantravadi, Alexis Ogdie, Walter K KraftExpert Review of Clinical Pharmacology|August 13, 2024
Hydroxyurea in the sickle cell disease modern eraChazmyn Riley, Walter K Kraft, Robin MillerPediatric Clinics of North America|October 6, 2012
Pharmacologic management of the opioid neonatal abstinence syndromeWalter K Kraft, John N van den AnkerExpert Review of Clinical Pharmacology|January 14, 2014
Aprepitant for the prevention of nausea and vomiting associated with chemotherapy and postoperative recoveryJennifer Larusso, Scott A Waldman, Walter K KraftPageof 11